| Mobile Web

Search results for U.S. Food and Drug Administration

Industry

Johnson & Johnson\'s Ottava surgical robot wins U.S. FDA approval

Johnson & Johnson has secured U.S. marketing approval for its Ottava surgical robot system, marking its official entry into the robotic surgery market. The U.S. Food and Drug Administration granted approval through the De Novo pathway, allowing use of Ottava in 10 types of general surgery involving the upper abdomen, including gastrectomy and cholecystectomy. The approval may intensify competition in a market long dominated by Intuitive Surgical\'s da Vinci system, alongside Medtronic.

Industry

U.S. biotech Axiom chooses Hong Kong over Nasdaq for first listing

U.S. biotech Axiom Biosciences has chosen Hong Kong, not a U.S. exchange, for its first stock market listing. The San Diego-based company is pursuing a Hong Kong listing in 2027 and is considering a secondary U.S. listing in 2029. Axiom expects Hong Kong to provide access to specialist biotech investors and expand cooperation with Asian clinical trial and commercialization partners amid shifting global biotech financing conditions.

Telecommunications & Media

Apple Watch Series 12 may drop Touch ID, focus on health features and battery

Apple\'s Apple Watch Series 12, expected this fall, may focus on performance, battery life and health features, with a new chip seen as the most notable change. Reports also suggest Apple is pursuing both a larger battery capacity and better power efficiency. Health features may include a new hypertension alert submitted for FDA review, while non-invasive blood glucose measurement remains years away. Touch ID appears increasingly unlikely.